{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:00:42Z","timestamp":1770508842446,"version":"3.49.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,12,21]],"date-time":"2007-12-21T00:00:00Z","timestamp":1198195200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1007\/s00228-007-0414-1","type":"journal-article","created":{"date-parts":[[2007,12,20]],"date-time":"2007-12-20T11:26:24Z","timestamp":1198149984000},"page":"267-273","source":"Crossref","is-referenced-by-count":82,"title":["Pharmacokinetics of eslicarbazepine acetate in patients with moderate hepatic impairment"],"prefix":"10.1007","volume":"64","author":[{"given":"Luis","family":"Almeida","sequence":"first","affiliation":[]},{"given":"J. Hendrick","family":"Potgieter","sequence":"additional","affiliation":[]},{"given":"Joana","family":"Maia","sequence":"additional","affiliation":[]},{"given":"M. Alida","family":"Potgieter","sequence":"additional","affiliation":[]},{"given":"Fernando","family":"Mota","sequence":"additional","affiliation":[]},{"given":"P.","family":"Soares-da-Silva","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2007,12,21]]},"reference":[{"key":"414_CR1","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1021\/jm980627g","volume":"42","author":"J Benes","year":"1999","unstructured":"Benes J, Parada A, Figueiredo AA, Alves PC, Freitas AP, Learmonth DA, Cunha RA, Garrett J, Soares-da-Silva P (1999) Anticonvulsant and sodium channel-blocking properties of novel 10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide derivatives. J Med Chem 42:2582\u20132587","journal-title":"J Med Chem"},{"key":"414_CR2","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1177\/0091270005279364","volume":"45","author":"L Almeida","year":"2005","unstructured":"Almeida L, Falc\u00e3o A, Maia J, Mazur D, Gellert M, Soares-da-Silva P (2005) Single-dose and steady-state pharmacokinetics of eslicarbazepine acetate (BIA 2-093) in healthy elderly and young subjects. J Clin Pharmacol 45:1062\u20131066","journal-title":"J Clin Pharmacol"},{"key":"414_CR3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2165\/00126839-200304050-00001","volume":"4","author":"L Almeida","year":"2003","unstructured":"Almeida L, Soares-da-Silva P (2003) Safety, tolerability and pharmacokinetic profile of BIA 2-093, a novel putative antiepileptic agent, during first administration to humans. Drugs R D 4:269\u2013284","journal-title":"Drugs R D"},{"key":"414_CR4","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1177\/0091270004267591","volume":"44","author":"L Almeida","year":"2004","unstructured":"Almeida L, Soares-da-Silva P (2004) Safety, tolerability, and pharmacokinetic profile of BIA 2-093, a novel putative antiepileptic, in a rising multiple-dose study in young healthy humans. J Clin Pharmacol 44:906\u2013918","journal-title":"J Clin Pharmacol"},{"key":"414_CR5","first-page":"191","volume":"46","author":"M Vaz-da-Silva","year":"2005","unstructured":"Vaz-da-Silva M, Nunes T, Soares E, Rocha JF, Tavares S, Falc\u00e3o A, Almeida L, Soares-da-Silva P (2005) Eslicarbazepine acetate pharmacokinetics after single and repeated doses in healthy subjects. Epilepsia 46:191","journal-title":"Epilepsia"},{"key":"414_CR6","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.nurt.2006.10.005","volume":"4","author":"L Almeida","year":"2007","unstructured":"Almeida L, Soares-da-Silva P (2007) Eslicarbazepine acetate (BIA 2-093) Neurotherapeutics 4:88\u201396","journal-title":"Neurotherapeutics"},{"key":"414_CR7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/bdd.549","volume":"28","author":"A Falcao","year":"2007","unstructured":"Falcao A, Maia J, Almeida L, Mazur D, Gellert M, Soares-da-Silva P (2007) Effect of gender on the pharmacokinetics of eslicarbazepine acetate (BIA 2-093), a new voltage-gated sodium channel blocker. Biopharm Drug Dispos 28:249\u2013256","journal-title":"Biopharm Drug Dispos"},{"key":"414_CR8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1528-1167.2007.00984.x","volume":"48","author":"C Elger","year":"2007","unstructured":"Elger C, Bialer M, Cramer JA, Maia J, Almeida L, Soares-da-Silva P (2007) Eslicarbazepine acetate: a double-blind, add-on, placebo-controlled exploratory trial in adult patients with partial-onset seizures. Epilepsia 48:497\u2013504","journal-title":"Epilepsia"},{"key":"414_CR9","unstructured":"EMEA\/CHMP Guideline on the Evaluation of the Pharmacokinetics of Medicinal Products in Patients with Impaired Hepatic Function (2005). Committee for Medicinal Products for Human Use, European Medicines Agency, London"},{"key":"414_CR10","unstructured":"FDA\/CDER Guidance for Industry Pharmacokinetics in Patients with Impaired Hepatic Function \u2013 Study Design, Data Analysis, and Impact on Dosing and Labeling (2003). Food and Drug Administration, U.S. Department of Health and Human Services, Centre for Drug Evaluation and Research, Washington D.C."}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-007-0414-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-007-0414-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-007-0414-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T08:51:45Z","timestamp":1558687905000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-007-0414-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,21]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["414"],"URL":"https:\/\/doi.org\/10.1007\/s00228-007-0414-1","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,21]]}}}